WFS1蛋白调控醛固酮合成的作用及机制研究
批准号:
82100833
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
杨溢
依托单位:
学科分类:
肾上腺及相关疾病
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
杨溢
中文摘要
醛固酮瘤的核心病理生理特征为自主(过度)醛固酮分泌,其患者的心脑血管并发症显著增加。醛固酮瘤中醛固酮合成的调控机制尚未完全阐明。我们前期通过4D蛋白质组学发现醛固酮瘤中WFS1的表达显著增高;进一步功能实验证实:在HAC15细胞中过表达WFS1可显著增加其醛固酮合成;后续干预实验提示WFS1可能通过三磷酸肌醇受体促进内质网钙离子流入胞浆,激活钙离子信号通路,调控醛固酮合成。基于前期基础,本项目拟开展以下研究:1)通过肾上腺特异性WFS1高表达的小鼠模型,以及WFS1高/低表达的HAC15细胞和醛固酮瘤原代细胞,明确WFS1对醛固酮合成的调控作用;2)利用siRNA、抑制剂干预和蛋白质免疫共沉淀等多种实验手段,阐明WFS1调控醛固酮合成的分子机制;3)在已建立的醛固酮瘤样本库中,对WFS1相关通路进行再验证。本研究有望进一步阐明醛固酮瘤中醛固酮合成的调控机制,并为其药物治疗提供新的干预靶点。
英文摘要
Aldosterone producing adenoma (APA) is pathophysiologically characterized by autonomous (excessive) aldosterone secretion. The cardiovascular and cerebrovascular complications in patients with APA have increased dramatically. The regulatory mechanism of aldosterone synthesis in APA has not been fully elucidated. We previously found through 4D proteomics that the expression of WFS1 was significantly increased in APA. Further functional experiments confirmed that the overexpression of WFS1 in HAC15 cells significantly increased its aldosterone synthesis. Subsequent intervention experiments suggested that WFS1 may promote the efflux of Ca2+ from endoplasmic reticulum to cytoplasm through triphosphate inositol receptors, activating calcium signaling pathway and thus regulating aldosterone synthesis. Based on our preliminary data, this project aims to carry out the following experiments: 1) To investigate the regulatory effect of WFS1 on aldosterone synthesis through a mouse model with adrenal specific overexpression of WFS1, HAC15 cell and APA primary culture cell with over/down expression of WFS1; 2) To clarify the molecular mechanism of WFS1 in regulating aldosterone synthesis by techniques such as siRNA or inhibitor treatment and immunoprecipitation etc.; 3)To verify the WFS1-related pathways in an APA sample library established previously. This study is expected to further clarify the regulatory mechanism of aldosterone synthesis in APA and provide a novel intervention target for its medical therapy.
背景:醛固酮瘤的核心病理生理特征为自主(过度)醛固酮分泌,其患者的心脑血管并发症显著增加。醛固酮瘤中醛固酮合成的调控机制尚未完全阐明。 .主要研究内容:本研究首先开展醛固酮瘤蛋白质组学、蛋白质磷酸化组学,进行通路富集分析,并在醛固酮瘤组织中验证WFS1表达。然后,构建高醛固酮的小鼠模型和高/低表达WFS1的肾上腺细胞模型,检测WFS1水平,醛固酮合成通路和钙离子合成通路、线粒体功能。最后,在WFS1过表达细胞模型中,通过通过钙离子螯合剂和IP3依赖性线粒体钙摄取阻滞剂干预,检测醛固酮合成通路。.结果:在醛固酮瘤中,内分泌和其他因素调节的钙重吸收通路在醛固酮瘤中显著上调,其中WFS1是上调最显著的差异蛋白;进一步验证分析提示醛固酮瘤中WFS1的表达与APA患者确诊试验后醛固酮和收缩压显著正相关。在小鼠模型中,我们发现Wfs1表达与血浆醛固酮浓度和Cyp11b2表达也有较好的相关性。在H295R细胞中,转染WFS1可显著上调CYP11B2的表达和细胞上清醛固酮的水平;WFS1慢病毒干扰可显著下调CYP11B2的表达和细胞上清醛固酮的水平。在HEK293细胞中,转染WFS1可显著上调CYP11B2的启动子活性。WFS1转染伴有H295R细胞胞浆钙离子浓度增加和线粒体ATP合成增加;钙离子螯合剂干预和IP3依赖性线粒体钙摄取阻滞剂干预可显著降低WFS1介导的CYP11B2表达增高和细胞上清醛固酮水平增加。 .结论:WFS1在醛固酮瘤中表达增高,并且可通过上调钙离子通路和影响线粒体功能调控醛固酮合成。
CXC趋化因子配体12靶向趋化因子受体4/磷脂酶Cβ/三磷酸肌醇/钙离子通路调控醛固酮合成的机制研究
-
批准号:--
-
项目类别:省市级项目
-
资助金额:0.0万元
-
批准年份:2025
-
负责人:杨溢
-
依托单位:
国内基金
海外基金